Literature DB >> 33482759

Progressive retinal vessel malformation in a premature infant with Sturge-Weber syndrome: a case report and a literature review of ocular manifestations in Sturge-Weber syndrome.

Zhengping Hu1,2, Jian Cao3,4, Eun Young Choi1,2, Yun Li5,6.   

Abstract

BACKGROUND: Sturge-Weber syndrome is a disorder marked by a distinctive facial capillary malformation, neurological abnormalities, and ocular abnormalities such as glaucoma and choroidal hemangioma. CASE
PRESENTATION: We report a case of progressively formed retinal vessel malformation in a premature male infant with Sturge-Weber syndrome and retinopathy of prematurity, after treatment with intravitreal anti-vascular endothelial growth factor (VEGF). The baby was born at 30 weeks gestation with a nevus flammeus involving his left eyelids and maxillary area. On postmenstrual age week 39, he received intravitreal anti-VEGF. Diffuse choroidal hemangioma became evident at 40 weeks, with the classic "tomato catsup fundus" appearance. These clinical findings characterized Sturge-weber syndrome. He presented with posterior retinal vessel tortuosity and vein-to-vein anastomoses at 44 weeks.
CONCLUSION: This is a rare case of documented progression of retinal vessel malformations in a patient with Sturge-Weber syndrome and retinopathy of prematurity.

Entities:  

Keywords:  Diffuse choroidal hemangioma; Nevus flammeus; Ocular manifestation; Retinal vessel malformation; Sturge-weber syndrome

Mesh:

Year:  2021        PMID: 33482759      PMCID: PMC7821406          DOI: 10.1186/s12886-021-01815-8

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


  86 in total

Review 1.  Understanding retinopathy of prematurity: update on pathogenesis.

Authors:  José Carlos Rivera; Przemyslaw Sapieha; Jean-Sébastien Joyal; François Duhamel; Zhuo Shao; Nicholas Sitaras; Emilie Picard; Ellen Zhou; Pierre Lachapelle; Sylvain Chemtob
Journal:  Neonatology       Date:  2011-10-03       Impact factor: 4.035

Review 2.  Photodynamic therapy of choroidal hemangioma in sturge-weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas.

Authors:  Michael S Tsipursky; Pamela R Golchet; Lee M Jampol
Journal:  Surv Ophthalmol       Date:  2010-11-13       Impact factor: 6.048

Review 3.  Advances in Sturge-Weber syndrome.

Authors:  Anne M Comi
Journal:  Curr Opin Neurol       Date:  2006-04       Impact factor: 5.710

4.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

Review 5.  Evisceration in patients with Sturge-Weber syndrome.

Authors:  Helen Merritt; Margaret L Pfeiffer; Margaret E Phillips; Karina Richani
Journal:  Orbit       Date:  2017-02-01

6.  Bilateral exudative retinal detachments in Sturge-Weber syndrome.

Authors:  Sai H Chavala; Jennifer F Williamson
Journal:  Lancet       Date:  2013-02-01       Impact factor: 79.321

7.  Sturge-Weber syndrome: Continued vigilance is needed.

Authors:  Saeed Hassan; Amir Babiker; Fahad A Bashiri; Hamdi H Hassan; Maha El Husseini; Mustafa A Salih
Journal:  Sudan J Paediatr       Date:  2015

8.  Ciliochoroidal effusion induced by topical latanoprost in a patient with sturge-weber syndrome.

Authors:  Hiroshi Sakai; Nariko Sakima; Yoshimi Nakamura; Yuko Nakamura; Kazuhisa Hayakawa; Shoichi Sawaguchi
Journal:  Jpn J Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 2.447

9.  GNAQ mutation R183Q as a potential cause of familial Sturge-Weber syndrome: A case report.

Authors:  Zhengyi Huang; Yuchi Li; Zengxia Zhao; Jun Hu; Xiaoxin Tong; Xuhui Chen; Shuyun Liu; Xiaonan Xu; Yongjun Tao; Tingting Wang; Xin Cheng; Yangyang Dai; Yaoting Gui; Jun Wu
Journal:  Oncol Lett       Date:  2017-03-01       Impact factor: 2.967

10.  Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity.

Authors:  Samir N Patel; Michael A Klufas
Journal:  Eye Brain       Date:  2019-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.